FINANCIALS

CRSP Crispr Therapeutics Ag 1674416

Income Statement
Revenue	crsp-20240930	602,000
Net Income	crsp-20240930	-85,942,000
Profit Margin		-14276.08%

Balance Sheet
Current Assets	1,943,891,000
Assets	2,256,130,000
Current Liabilities	89,810,000
Liabilities	316,472,000
Equity	1,939,658,000
Shares Out	85,168,000

Cash Flow Statement
Operating Cash Flow	-92,743,000
Investing Cash Flow	-386,309,000

Market Analysis
Market Cap	4,237,115,960
Price	40.53
BVPS	22.77
PB	1.78
EPS	-3.21
PS	1759.60
FCF	-479,052,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view CRSP documents filed with the SEC.

CRSP Filings Clear

View A List of Tickers